Tse Wen Chang
Tse Wen Chang (, born August 25, 1947) is an immunology researcher, whose career spans across academia and industry. His early research involving the Immunoglobulin E (IgE) pathway and antibody-based therapeutics lead to the development of omalizumab (also known as Xolair), a medication that has been approved for the treatment of severe allergic asthma and severe chronic spontaneous urticaria. Chang is a cofounder of Tanox, a biopharmaceutical company specialized in anti-IgE therapies for the treatment of allergic diseases. After Tanox's tripartite partnership with Genentech and Novartis was forged in 1996, Chang returned to his alma mater, the National Tsing Hua University in Taiwan and served as the Dean (1996–1999) of the College of Life Sciences. Chang was appointed by the Taiwanese government as President of the Development Center for Biotechnology (DCB) in 2000, and served as a Science and Technology Advisor of the Executive Yuan from 2002 to 2006. From 2006 to 2016, he was tenured as Distinguished Research Fellow at the Genomics Research Center, Academia Sinica. He founded Immunwork, Inc. in 2014.
Q79455
Immunoglobulin E
Concept
Q79460
antibody
Concept
Q415392
omalizumab
Concept
Q415392
Xolair
Concept
Q35869
asthma
Concept
Q187440
urticaria
Concept
Q7683742
Tanox
ORG
Q79455
IgE
Concept
Q899140
Genentech
ORG
Q507154
Novartis
ORG
Q43406
National Tsing Hua University
ORG
Q11626123
Science and Technology
ORG
Q715055
Executive Yuan
ORG
Q337266
Academia Sinica
LOC
Q30089936
Tse Wen Chang
PER
1947-08-25T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
August 25, 1947
DATE
1996-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
1996
DATE
2000-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
2000
DATE
2002-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
2002
DATE
2006-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
2006
DATE
2006-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
2006
DATE
2016-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
2016
DATE
2014-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
2014
DATE
+1996^^http://www.w3.org/2001/XMLSchema#decimal
1996
NUMBER
+1999^^http://www.w3.org/2001/XMLSchema#decimal
1999
NUMBER
date of birth
subclass of
medical condition treated
medical condition treated